Post My Press Release

Free Press Release Distribution

Category: Medical Devices (Page 1 of 69)

Biodetectors And Accessories Market Analysis By Size ,Share , Industry Growth And Future Assumptions Till 2022 : Grand View Research Inc.

San Francisco, 16 May 2019: The Report Biodetectors And Accessories Market Size And Forecasts By Product (Instruments, Reagents & Media, Accessories & Consumables), By Application (Clinical, Food & Environmental, Defense), By End-use (Point of Care Testing, Diagnostics, Research Laboratories) And Trend Analysis From 2012 – 2022

Global Biodetectors And Accessories Market is expected to reach USD 14.9 billion by 2022, according to a new study by Grand View Research, Inc.Increasing prevalence of airborne and contact diseases such as anthrax, coronavirus, and plague is a high impact rendering driver of biodetectors and accessories market.

According to the World Health Organization (WHO),plague is a severe air-borne disease with casefatality ratio of 30%-60% and there were 783 cases reported globally in 2013. Moreover, continuous deterioration of environmental conditions as a consequence of increasing pollution is anticipated to induce demand for biodetectors and accessories market.

Furthermore, the advent of technologically-advanced products such as microfluidics-based detectors, micro arrays, PCR, and electrochemiluminescence-based devices is anticipated to propel demand for biodetectors in a wide range of applications, thereby fueling growth of overall market over the forecast period. For instance, in November 2015, Smiths Detection launched TRACE-PRO, probe-based non-radioactive explosives detector.

This product exhibited enhanced speed and increased efficiency of the sample screening. The aforementioned factors are expected to serve as key contributing factors towards growth of biodetectors and accessories market over the forecast period.

Access Research Report of Biodetectors And Accessories Market @ www.grandviewresearch.com/industry-analysis/biodetectors-accessories-market

Further key findings from the study suggest: 

  • In 2014, instruments dominated the product segment, accounting for a revenue share of over 35.0%, owing to its incorporation in a wide range of applications such as biohazard detection, pharmaceutical research, and forensic sciences
  • The clinical applications market held a substantial share constituting of over 44.0% of the overall revenue owing to rising incorporation of biodetector kits & reagents in DNA analysis, human cell identification, laboratory-based pathogen testing, and toxin detection and identification.
  • Point of care testing dominated the end-use segment as a consequence of rising penetration of these devices in medical analytics, toxicology, drug screening, and rapid diagnosis of heart diseases through detection of biomarkers. Other end-use segment inclusive of biodefense is anticipated to be the fastest growing market owing to rising R&D investments in chemical detection systems coupled with high threat of bioterrorism and disease outbreaks.
  • Some key players catering to this industry are BioDetection Instruments, Inc., PositiveID Corporation, BioDetection Systems, Bertin Technologies, BBI Detection,Smith Detection, MSA the Safety Company, Research International, Shimadzu Corporation, Agilent Technologies, Bio Rad Laboratories, Thermo Fisher Scientific, Response BioMedical, Corp.,Physical Sciences, Inc., NetBio, Inc., andMBio Diagnostics, Inc.
  • New product development in an attempt to cater to the changing consumer requirements, is a viable sustainability strategy adopted by these market participants. For instance, in November 2015, PositiveID Corporation developed “New Firefly Dx Prototype System” with enhanced PCR capabilities enabling the detection of multiple pathogens in lower quantities.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented biodetectors and accessories market on the basis of product, application, end-use,and region:

Global biodetectors and accessories product outlook (Revenue, USD Million, 2012 – 2022)

  • Instruments
  • Reagents & Media
  • Accessories & Consumables

Global biodetectors and accessories application outlook (Revenue, USD Million, 2012 – 2022)

  • Clinical
  • Food & Environmental
  • Defense

Global biodetectors and accessories end-use outlook (Revenue, USD Million, 2012 – 2022)

  • Point Of Care Testing
  • Diagnostics
  • Research Laboratories
  • Others

Biodetectors and accessories regional outlook (Revenue, USD Million, 2012 – 2022)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • MEA

Access Press Release of Biodetectors And Accessories Market @ www.grandviewresearch.com/press-release/global-biodetectors-accessories-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Congestive Heart Failure (CHF) Treatment Devices Market Latest Report By Industry Size ,Share ,Growth Analysis And Forecast To 2024 : Grand View Research Inc.

San Francisco, 21 May 2019: The Report Congestive Heart Failure (CHF) Treatment Devices Market Analysis by Product (Ventricular Assist Devices, Counter Pulsation Devices, Implantable Cardioverter Defibrillators, Pacemakers, Cardiac Resynchronization Therapy) And Segment Forecasts to 2024

The Congestive Heart Failure (CHF) Treatment Devices Market is expected to reach USD 32.0 billion by 2024, according to a new report by Grand View Research, Inc. The rising burden of CVDs is one of the prime factors responsible for lucrative growth of this vertical. Sedentary lifestyles, mental stress, and junk food consumption tendencies are the key factors responsible for development of CVDs.

Favorable reimbursement policies, such as the U.S. Medicare system, are observed to be a prime growth factor for this industry. Companies now provide new product platforms, which have reimbursement coverage that benefit the patient. The reimbursement can be availed for devices, such as Ventricular Assist Devices (VADs), Implantable Cardiovascular Defibrillators (ICDs), and pacemakers, which are used to treat CHF.

The industry participants are more focused on developing high-utility products, which can deliver personalized care. These advancements are improving the accuracy and provide additional capabilities to enhance the workflow and reduce the incidence of errors.

Access Research Report of Congestive Heart Failure (CHF) Treatment Devices Market @ www.grandviewresearch.com/industry-analysis/congestive-heart-failure-treatment-devices-market

Further key findings from the study suggest:

  • The market by product is segmented into VADs, Counter Pulsation Devices, ICDs, pacemakers, and cardiac resynchronization devices. The ICD segment consisting of two types, transvenous and subcutaneous, held a lucrative share in 2015, which was followed by the pacemaker’s segment. This can be attributed to the fact that defibrillators and pacemakers form the primary line of treatment administered for heart failure.
  • On the other hand, the VAD segment is anticipated to grow at a significant rate over the forecast period due to reimbursement coverage and technological advancements in VADs.
  • The VAD based on the site of implantation are categorized into Left Ventricular Assist Devices (LVAD) and Right Ventricular Assist Devices (RVAD). When the LVAD and RVAD are implanted together they are termed Biventricular Assist Devices (BIVAD).
  • North America dominated the overall market in terms of revenue share at over 40.0% in 2015; this can be attributed to the presence of a large population base suffering from CVDs coupled with a significant geriatric population base.
  • Asia-Pacific is anticipated to grow at a lucrative CAGR during the forecast period due to the increasing demand for these products. Furthermore, the rapidly improving healthcare infrastructure in the countries, such as India and Japan, also contribute toward the growth of this region.
  • Some of the players in this industry are Berlin Heart Inc., Medtronic, Boston Scientific, World Heart Corporation, Biotronik, Jarvik Heart, MicroMed Cardiovascular Inc., Teleflex Inc., and St. Jude Medical.
  • The market participants are actively involved in the improvement of the current product portfolio, in order to sustain their market position. Additionally, drug development and their market entry in the untapped nations are expected to propel market growth.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the global CHF treatment devices market on the basis of product.

Global CHF Treatment Devices Market by Product (USD Million), 2013 – 2024

  • Ventricular Assist Devices (VADs)
    • LVAD
    • RVAD
    • BiVAD
  • Counter Pulsation Devices
  • Implantable Cardioverter Defibrillators
    • Transvenous ICD
    • Subcutaneous ICD
  • Pacemakers
    • Implantable
    • External
  • Cardiac Resynchronization therapy
    • Cardiac Resynchronization Therapy-Defibrillators (CRT-D)
    • Cardiac Resynchronization Therapy-Pacemakers (CRT-P)

CHF Treatment Devices Market by Region (USD Million), 2013 – 2024

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • MEA

Access Press Release of Congestive Heart Failure (CHF) Treatment Devices Market @ www.grandviewresearch.com/press-release/global-congestive-heart-failure-chf-treatment-devices-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Atherectomy Devices Market Key Players ,Future Growth, Industry Size, Tends And Forecast Till 2025 : Grand View Research Inc.

San Francisco, 24 May 2019: The Report Atherectomy Devices Market Analysis By Type (Directional Atherectomy, Rotational Atherectomy, Orbital Atherectomy, Laser Atherectomy), By Region (North America, Europe, Asia Pacific, Latin America, MEA), And Segment Forecasts, 2018 – 2025

The global Atherectomy Devices Market is expected to reach USD 894.69 million by 2025, based on a new report by Grand View Research, Inc. The demand for atherectomy devices market is anticipated to boost over the forecast period due to rapidly rising incidence of target diseases such as peripheral artery disease.

New technologies and product approvals are expected to boost the market for orbital and laser atherectomy devices over the forecast period. For instance, in July 2016, Cardiovascular Systems Inc. submitted an application for approval to Pharmaceuticals and Medical Devices Agency (PMDA), Japan’s regulatory agency for pharmaceuticals and medical devices. The company intends to launch Diamondback 360 Coronary OAS Micro Crown in the region and is looking for potential distributors. This would be the company’s first international market entry and the approval procedure is yet to be completed.

Access Research Report of Atherectomy Devices Market @ www.grandviewresearch.com/industry-analysis/atherectomy-device-market

Further Key Findings from the Study Suggest:

  • Directional atherectomy devices was the largest segment in terms of revenue in the year 2016. This can be attributed to their capability of collecting the shaved plaque in a collecting space, which reduces the risk of barotrauma, dissection, and neointimal hyperplasia.
  • Laser atherectomy devices is expected to the fastest growing segment over the next 8 years. Laser technique is perceived as to have more precision in plaque removal and cause fewer complications. It is also believed to result in lesser incidence of restenosis.
  • Geographically, North America held the largest market share in 2015 and is expected to maintain its position during the forecast period. A high prevalence of Peripheral Artery Diseases (PAD) in this region is one of the key reasons for high demand of atherectomy. Almost 8.5 million people suffer from PAD in the U.S., resulting in an annual economic burden of nearly USD 160 million.
  • Asia Pacific is anticipated to observe the fastest growth over the coming years. Improving economic conditions leading to increasing prevalence of lifestyle diseases, especially cardiovascular and peripheral, is the key reason for this growth.
  • Some of the key industry contributors are Boston Scientific Corporation, Cardiovascular Systems Inc., Medtronic (Covidien), Spectranetics, VOLCANO CORPORATION, Avinger Inc., Bayer AG, Straub Medical AG, ST. JUDE MEDICAL, BARD Peripheral Vascular, Cardinal Health (Cordis), and Terumo IS.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the atherectomy devices market by type and region:

Atherectomy Devices Type Outlook (Market Revenue in USD Million, 2014 – 2025)

  • Directional atherectomy devices
  • Rotational atherectomy devices
  • Orbital atherectomy devices
  • Laser atherectomy devices

Atherectomy Devices Regional Outlook (Market Revenue in USD Million, 2014 – 2025)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Access Press Release of Atherectomy Devices Market www.grandviewresearch.com/press-release/global-atherectomy-device-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Bariatric Surgery Devices Market Global Industry Demand ,Analysis And Forecast To 2022 : Grand View Research Inc.

San Francisco, 16 May 2019: The Report Bariatric Surgery Devices Market Size, Share & Trends Analysis Report By Procedures (Adjustable Gastric Band, Vertical Sleeve Gastrectomy, Roux-en-Y Gastric Bypass), And Segment Forecasts, 2012 – 2022

The global Bariatric Surgery Devices Market is expected to reach USD 2.8 billion by 2022, according to a new report by Grand View Research, Inc. The growing incidence rate of obesity has led to many government initiatives at regional as well as global level to increase the awareness related to obesity and undertake various incidence curbing action plans. For instance, the South Wales government launched the NSW Healthy Eating and Active Living Strategy 2013-2018 for preventing obesity.

In addition, to strategic planning, the governments of developed nations are also funding universities to design strategic interventions to control the rising obesity. For the year 2014, New Zealand invested USD 40 million for its Healthy Families NZ anti-obesity initiative. Moreover, industry players are also trying to tackle the rising problem of obesity by launching new products. In February 2017, a startup company, Allurion Technologies, located in Massachusetts, U.S. filed a regulatory filing to report the USD 19 million raised amount out of the target of USD 27 million. The funds were intended to use for the development non-endoscopic gastric balloon, Ellipse. This device is in the form of capsule which when swallowed, is inflated in the stomach and deflates after months and is passed out without the need for anesthesia for its removal. This device is anticipated to revolutionize the bariatric surgery devices market due to its ease of use over the forecast period

The demand for non-invasive surgeries is also increasing, as non-invasive surgeries save time, cost, and decrease hospital stay. Governments are also encouraging the use of more incisionless surgeries in order to decrease the cases of infection. For instance, in July 2015, the FDA approved a balloon device, where the balloon is directly swallowed using a sterile solution.

Access Research Report of Bariatric Surgery Devices Market @ www.grandviewresearch.com/industry-analysis/bariatric-surgery-devices-industry

Further Key Findings from the Report Suggest:

  • Gastric bypass surgery dominated the market in 2014 due to its early adoption since 1960 and the fact that it is the combination of both restrictive and malabsorptive procedures.
  • The sleeve gastrectomy surgery is expected to witness rapid rise in demand owing to, the procedure’s incision-less nature. The fact that the procedure does not involve re-routing the intestine is also likely to drive segment growth. With the FDA approval of ReShape balloon, there has been a recent FDA filing for Ellipse device, which is swallowed and gets excreted naturally after four months.
  • North America was the largest regional market owing to the presence of market players introducing innovative technologies to improve patient care.
  • Favorable government initiatives are also expected to play pivotal roles in the European market growth. For instance, the German Federal Ministry of Education and Research (BMBF) formed two funding research programs namely the Competence Network Obesity and Integrated Research and Treatment Center (IFB) Adiposity Diseases with budgets allocated at around USD 26 million for 2012-2015.
  • Asia Pacific followed North America in terms of obesity and overweight prevalence. This coupled with the presence of large untapped opportunities is expected to help the Asia Pacific bariatric surgery market register the fastest growth over the forecast period.
  • Some key players of this market include Covidien Plc, Intuitive Surgical Inc., TransEnterix Inc., Allergan Inc., USGI Medical Inc., Semiled Ltd., Cousin Biotech, GI Dynamics Inc., Johnson and Johnson and Mediflex Surgical Product.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the bariatric surgery devices market report on the basis of procedures:

Procedure Outlook (Revenue, USD Million, 2012 – 2022)

  • Adjustable Gastric Band (AGB)
  • Vertical Sleeve Gastrectomy (VSG)
  • Roux-en-Y Gastric Bypass (RYGB)
  • Biliopancreatic Diversion with a Duodenal Switch (BPD-DS)

Regional Outlook (Revenue, USD Million, 2012 – 2022)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • MEA

Access Press Release of Bariatric Surgery Devices Market @ www.grandviewresearch.com/press-release/global-bariatric-surgery-devices-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Clot Management Devices Market Overview and Top Players Forecast Till 2024: Grand View Research Inc.

San Francisco, 21 May 2019: The Report Clot Management Devices Market Analysis By Product (Neurovascular Embolectomy Devices, Embolectomy Balloon Catheters, Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis Devices), By End User, And Segment Forecasts 2018 – 2024

The global Clot Management Devices Market was valued at USD 1.26 billion in 2015 and is further expected to reach a value of USD 1.88 billion by 2024, according to a new report by Grand View Research, Inc. The market is expected to grow with a CAGR of 4.6% owing to the key drivers such as increasing prevalence of stroke, Pulmonary Embolism (PE), Deep Vein Thrombosis (DVT), obesity, growing geriatric population, technological advancements, and improvement in health insurance coverage & availability of emergency medical services.

Globally, the number of people impacted by PE and DVT, which are collectively known as Venous Thromboembolism (VTE), is much larger than AIDS, cancer, and road traffic accidents combined together.

The data published by the U.S. CDC indicates that stroke is amongst the leading cause of disabilities and is the fifth leading cause of deaths in the U.S. According to the estimates of CDC, PE and DVT affect nearly 900,000 people in the U.S. Furthermore, the CDC estimates also suggest the following:

  • Approximately 60,000 to 100,000 Americans die due to VTE and nearly 10% to 30% of the people are expected to die within 1 month of their diagnosis
  • Nearly 33% of the people with VTE will have a recurrence within 10 years
  • In the U.S.,VTE accounts for over USD 10 billion in medical costs

The various risk factors that lead to VTE and stroke are classified as high, medium, and other risks. The high risk factors include hospitalization; spinal, hip, knee, & cancer surgeries; and inactivity for long time due to various reasons, such as postsurgery, sedentary lifestyle, etc. The moderate risk factors include age above 60 years, family history of blood clots, chemotherapy, and excessive use of estrogen-based medications. The other risk factors include obesity, pregnancy, smoking, and alcohol consumption.

The clot management devices market is also anticipated to grow due to technological advancements and the launch of new-generation thrombectomy devices, such as Penumbra’s AC68 Reperfusion Catheter; Trevo clot retrieval device manufactured by the Concentric Medical, Inc.; and EmboTrap II Revascularization Device manufactured by Neuravi.

Access Research Report of Clot Management Devices Market @ www.grandviewresearch.com/industry-analysis/clot-management-devices-market

Further Key Findings from the Study Suggest:

  • In 2015, percutaneous thrombectomy devices accounted for the maximum share of over 35%. However, the neurovascular embolectomy devices segment is expected to register the maximum CAGR of 6.2% over the forecast period
  • Hospitals accounted for the maximum share of over 80%, as majority of the stroke, DVT, and PE cases are treated in emergency and critical care units. The demand for low-risk clot removal procedures is anticipated to drive the diagnostic center segment.
  • In 2015, North America held the majority revenue share of over 60.5%. The growing awareness about DVT/PE, access to advanced healthcare facilities, and presence of robust reimbursement and regulatory framework are some of the key reasons attributed to the high market share.
  • Asia Pacific is anticipated to be the fastest growing region with a CAGR of 5.7% over the forecast period.
  • Some of the key players in the clot management devices market include Boston Scientific Corporation; Edwards Lifesciences; Teleflex; Vascular Solutions, Inc.; Straub Medical; LeMaitre Vascular; Medtronic; iVascular; and others

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the clot management devices market by product, end user and region:

Clot Management Devices Product Outlook (Revenue, USD Million; 2013 – 2024)

  • Neurovascular Embolectomy Devices
  • Embolectomy Balloon Catheters
  • Percutaneous Thrombectomy Devices
  • Catheter-Directed Thrombolysis (CDT) devices
  • Inferior VenaCava Filters (IVCF)

Clot Management Devices End-User Outlook (Revenue, USD Million; 2013 – 2024)

  • Hospitals
  • DiagnosticCenters

Clot Management Devices Regional Outlook (Revenue, USD Million; 2013 – 2024)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • MEA

Access Press Release of Clot Management Devices Market @ www.grandviewresearch.com/press-release/global-clot-management-devices-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Global Cardiopulmonary Stress Testing System Market Trends, Analysis, Leading Players & Future Forecast by 2028

May 27, 2019: The global Cardiopulmonary Stress Testing System market was valued at $XX million in 2017, and Radiant Insights Research analysts predict the global market size will reach $XX million by the end of 2028, growing at a CAGR of XX% between 2017 and 2028.

This report provides detailed historical analysis of global market for Cardiopulmonary Stress Testing System from 2013-2018, and provides extensive market forecasts from 2018-2028 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Cardiopulmonary Stress Testing System market.

Leading players of Cardiopulmonary Stress Testing System including:

  • CareFusion Corporation
  • COSMED
  • GE Healthcare
  • Philips Healthcare
  • Schiller AG
  • Welch Allyn
  • SunTech Medical
  • Spacelabs Healthcare
  • Nihon Kohden Corporation
  • MGC Diagnostics Corporation

To Request A Sample Copy Of This Report at:  https://www.radiantinsights.com/research/2013-2028-report-on-global-cardiopulmonary-stress-testing-system-market/request-sample

Market split by Type, can be divided into:

  • Cardiopulmonary Exercise Testing (CPET) Systems
  • Stress ECG
  • Pulse Oximeters
  • Stress Blood Pressure Monitors
  • SPECT

Market split by Application, can be divided into:

  • Hospital
  • Clinic
  • Home Use

Market split by Sales Channel, can be divided into:

  • Direct Channel
  • Distribution Channel

Market segment by Region/Country including:

  • North America (United States, Canada and Mexico)
  • Europe (Germany, UK, France, Italy, Russia and Spain etc.)
  • Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)
  • South America Brazil, Argentina, Colombia and Chile etc.)
  • Middle East & Africa (South Africa, Egypt, Nigeria and Saudi Arabia etc.)

Table of Contents

Chapter 1 Cardiopulmonary Stress Testing System Market Overview
1.1 Cardiopulmonary Stress Testing System Definition
1.2 Global Cardiopulmonary Stress Testing System Market Size Status and Outlook (2013-2028)
1.3 Global Cardiopulmonary Stress Testing System Market Size Comparison by Region (2013-2028)
1.4 Global Cardiopulmonary Stress Testing System Market Size Comparison by Type (2013-2028)1.5 Global Cardiopulmonary Stress Testing System Market Size Comparison by Application (2013-2028)
1.6 Global Cardiopulmonary Stress Testing System Market Size Comparison by Sales Channel (2013-2028)
1.7 Cardiopulmonary Stress Testing System Market Dynamics
1.7.1 Market Drivers/Opportunities
1.7.2 Market Challenges/Risks
1.7.3 Market News (Mergers/Acquisitions/ Expansion)

Chapter 2 Cardiopulmonary Stress Testing System Market Segment Analysis by Player

2.1 Global Cardiopulmonary Stress Testing System Sales and Market Share by Player (2016-2018)
2.2 Global Cardiopulmonary Stress Testing System Revenue and Market Share by Player (2016-2018)
2.3 Global Cardiopulmonary Stress Testing System Average Price by Player (2016-2018)
2.4 Players Competition Situation & Trends
2.5 Conclusion of Segment by Player

To Browse Full Research Report @:
https://www.radiantinsights.com/research/2013-2028-report-on-global-cardiopulmonary-stress-testing-system-market

About Radiant Insights:
Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. It assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. The Organization has a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.

Media Contact:
Company Name: Radiant Insights, Inc
Contact Person: Michelle Thoras
Email: sales@radiantinsights.com
Phone: (415) 349-0054
Address: 201 Spear St #1100, Suite #3036
City: San Francisco
State: California
Country: United States
For more information, Visit: http://www.radiantinsights.com

Capsule Endoscopy Market Emerging Technology Trends And Forecast 2022: Grand View Research Inc.

San Francisco, 16 May 2019: The Report Capsule Endoscopy Market Analysis By Accessory (Wireless Capsule, Workstation & Recorder), By Product (Small Bowel, Esophageal, Colon), By Application (OGIB, Crohn’s, Small Intestine Tumors) And Segment Forecasts To 2022

Global capsule endoscopy market is expected to experience lucrative growth over the forecast period due to, the rising prevalence of gastrointestinal diseases, colorectal cancer, demand for faster and accurate diagnostics tools, and the presence of supportive government initiatives. Capsule endoscopy provides painless visualization of GI (gastrointestinal) tract images, transmitted via data recorder. Additionally, the introduction of technologically advanced capsules such as longer battery life and WiFi enabled are expected to further drive the growth of the capsule endoscopy market. The global capsule endoscopy market was valued at USD 454.7 million in 2014 and is expected to grow at a CAGR of 8.7% over the forecast period.

Access Research Report of Capsule Endoscopy Market @ www.grandviewresearch.com/industry-analysis/capsule-endoscopes-market

Further key findings from the study suggest:

  • Wireless capsules dominated the accessory market in 2014 and are also expected to register lucrative growth over the forecast period. Increasing usage rates of colon, small intestine and esophageal screening is expected to drive segment growth. In addition, presence of supportive reimbursement policies and the introduction of technologically advanced products are expected to serve this market as future growth opportunities.
  • Small bowel endoscopy capsule was the leading product segment of the market in 2014. These devices find wide applications in treating diseases such as suspected Crohn’s disease, inflammatory bowel disease, obscure GI tract bleeding and small bowel neoplastic lesions and this is expected to serve the segment as a high impact rendering driver. Increasing prevalence of target diseases is also expected to make significant contributions towards market growth.
  • Capsule endoscopy finds the largest application in OGIB (Obscure gastrointestinal bleeding) diagnosis owing to, increasing usage of wireless capsule endoscopes in vascular and inflammatory lesion diagnoses
  • North America was the largest regional capsule endoscopy market in 2014. The region’s market position is attributed to by factors such as presence of sophisticated healthcare infrastructure, supportive reimbursement policies and growing adoption rates of minimally invasive surgeries.
  • Asia Pacific region is anticipated to register rapid growth over the forecast period owing to, factors such as the presence of high unmet needs with respect to colorectal screening, rising disposable income and patient awareness levels and improving healthcare infrastructure
  • Key market players of the capsule endoscopy market include RF System lab, Olympus Corporation, Chongqing Jinshan Science & Technology (Group) Co., Given Imaging, Ltd., Fujifilm Holding Corporation, IntroMedic Co., Ltd and CapsoVision.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the global capsule endoscopy market on the basis of accessory, product, application and region:

Global Capsule Endoscopy Accessories Outlook (Revenue, USD Million, 2012 – 2022)

  • Wireless capsule
  • Workstation and receiver

Global Capsule Endoscopy Product Outlook (Revenue, USD Million, 2012 – 2022)

  • Small bowel
  • Esophageal
  • Colon

Global Capsule Endoscopy Application Outlook (Revenue, USD Million, 2012 – 2022)

  • OGIB
  • Crohn’s disease
  • Small Intestine tumor
  • Others (Celiac, NSAID reactions)

Capsule Endoscopy Regional Outlook (Revenue, USD Million, 2014 – 2022)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • MEA

Access Press Release of Capsule Endoscopy Market @ www.grandviewresearch.com/press-release/global-capsule-endoscopy-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Electrophoresis Technology Market by Technology, Application & Geography Analysis & Forecast to 2025

Electrophoresis is a separation technique that allows migration of charged particles under electric field effect. It is caused by presence of charged surface between particle surface and surrounding fluid. This technique is broadly used in chemistry for separating molecules by size, charge, or binding affinity. This technique has found an intensive denomination in DNA foot-printing and plasmid analysis for understanding of antibiotics resistant bacteria.

Major players operating in this market are Bio-Rad, Danaher Corporation, GE Healthcare, Thermo Fischer Corporation, Agilent Technologies, Sigma-Aldrich Corporation, and Qiagen.

Download Sample PDF Brochure at: https://www.alliedmarketresearch.com/request-toc-and-sample/1899

This report projects the global electrophoresis technology market with trends and opportunities and its demand by 2022. This research study includes qualitative and quantitative analysis with comprehensive research methodologies and reliable projection to create the present overview of the market and predict the market during the forecast period. Our research teams have used various secondary resources and directories such as industrial databases, journals, and magazines along with primary resources coupled with industry oriented measures such as industry related expert interviews to obtain key information and valuables, which makes it an asset for players in the market.

The global electrophoresis technology market has seen considerable advancement owing to its ever-increasing research applications. The polyacrylamide gel (2D PAGE) technique has fueled this market due to rise in field of proteomics. The development of support labelling, staining methods, and gel informatics is expected to be the principal driving force behind market growth. North America accounts for major share of the global electrophoresis market owing to increase in research on genomics and proteomics. Europe and Asia-Pacific is expected to countersign significant growth due to heavy investments and funding by biotechnology companies in these countries in innovative technologies. Time consumed by these technologies and presence of substitute methods is expected to be the only restraint hindering this market growth.

The global electrophoresis market is segmented based on application, type, technology, end-user industry, and geography. Based on applications as diagnostic application, research application, quality control, and process validation. Based on type it can be further categorized as high resolution, polyacrylamide, capillary, immuno-chemical, and others. Based on technology it can be categorized as gel, capillary, and others. Others are reagent and imaging, informatics. By end-user industry segmentation is done into laboratories, pharmaceuticals, hospitals, and others. Others are research organizations and academic institutions. Geographically, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Do Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/1899

Page 1 of 69

Powered by WordPress & Theme by Anders Norén